Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | EVP & CSO | March 10, 2017 | March 15, 2017 |
| Rubius Therapeutics, Inc.RUBY · Entity 116417 | Director | May 12, 2022 | May 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date March 10, 2017 · Filed March 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 321,905.531 |
Ending reported balance
After 2017-03-10 transaction · row 14
14 source rows · reconciled sequenceRow 1 · 2017-03-10 · Exercise / conversion · Acquired 2,740 · Balance 292,471.531 F1: Represents vesting of one-quarter of market share units granted on March 10, 2013. Row 2 · 2017-03-10 · Other · Acquired 1,343 · Balance 293,814.531 F2: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Row 3 · 2017-03-10 · Tax withholding · Disposed 2,022 · Balance 291,792.531 F3: Shares withheld for payment of taxes upon vesting of awards. Row 4 · 2017-03-10 · Exercise / conversion · Acquired 5,279 · Balance 297,071.531 F4: Represents vesting of one-quarter of market share units granted on March 10, 2014. Row 5 · 2017-03-10 · Other · Acquired 41 · Balance 297,112.531 F2: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Row 6 · 2017-03-10 · Tax withholding · Disposed 2,759 · Balance 294,353.531 F3: Shares withheld for payment of taxes upon vesting of awards. Row 7 · 2017-03-10 · Exercise / conversion · Acquired 4,982 · Balance 299,335.531 F5: Represents vesting of one-quarter of market share units granted on March 10, 2015. Row 8 · 2017-03-10 · Other · Disposed 653 · Balance 298,682.531 F6: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Row 9 · 2017-03-10 · Tax withholding · Disposed 2,245 · Balance 296,437.531 F3: Shares withheld for payment of taxes upon vesting of awards. Row 10 · 2017-03-10 · Exercise / conversion · Acquired 5,772 · Balance 302,209.531 F7: Represents vesting of one-quarter of market share units granted on March 10, 2016. Row 11 · 2017-03-10 · Other · Disposed 831 · Balance 301,378.531 F6: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Row 12 · 2017-03-10 · Tax withholding · Disposed 2,562 · Balance 298,816.531 F3: Shares withheld for payment of taxes upon vesting of awards. Row 13 · 2017-03-10 · Exercise / conversion · Acquired 47,953 · Balance 346,769.531 F8: Amount represents distribution of performance shares earned under the 2014-2016 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Row 14 · 2017-03-10 · Tax withholding · Disposed 24,864 · Balance 321,905.531 F3: Shares withheld for payment of taxes upon vesting of awards. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2017-03-10 | Direct | 0 |
Reported balance
After 2017-03-10 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2017-03-10 · Exercise / conversion · Disposed 2,740 · Balance 0 F9: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1: Represents vesting of one-quarter of market share units granted on March 10, 2013. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2018-03-10 | Direct | 5,280 |
Reported balance
After 2017-03-10 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2017-03-10 · Exercise / conversion · Disposed 5,279 · Balance 5,280 F9: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4: Represents vesting of one-quarter of market share units granted on March 10, 2014. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2019-03-10 | Direct | 9,966 |
Reported balance
After 2017-03-10 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2017-03-10 · Exercise / conversion · Disposed 4,982 · Balance 9,966 F9: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F5: Represents vesting of one-quarter of market share units granted on March 10, 2015. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2020-03-10 | Direct | 17,318 |
Reported balance
After 2017-03-10 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2017-03-10 · Exercise / conversion · Disposed 5,772 · Balance 17,318 F9: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7: Represents vesting of one-quarter of market share units granted on March 10, 2016. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2017-03-10 | Direct | 0 |
Reported balance
After 2017-03-10 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2017-03-10 · Exercise / conversion · Disposed 47,953 · Balance 0 F10: Each performance share converts into one share of common stock upon distribution in the first quarter of 2017, subject to a Total Shareholder Return modifier. F8: Amount represents distribution of performance shares earned under the 2014-2016 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents vesting of one-quarter of market share units granted on March 10, 2013.
F2: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.
F3: Shares withheld for payment of taxes upon vesting of awards.
F4: Represents vesting of one-quarter of market share units granted on March 10, 2014.
F5: Represents vesting of one-quarter of market share units granted on March 10, 2015.
F6: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
F7: Represents vesting of one-quarter of market share units granted on March 10, 2016.
F8: Amount represents distribution of performance shares earned under the 2014-2016 Long-Term Performance Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.
F9: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
F10: Each performance share converts into one share of common stock upon distribution in the first quarter of 2017, subject to a Total Shareholder Return modifier.
Rubius Therapeutics, Inc.
Report date May 12, 2022 · Filed May 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.24 · Expires 2032-05-11 | Direct | 25,000 |
Reported balance
After 2022-05-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-12 · Grant · Acquired 25,000 · Balance 25,000 F1: This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mural Oncology plc
Report date December 05, 2025 · Filed December 05, 2025
Section 16 reporting ended · disclosed 2025-12-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.56 · Expires 2035-06-10 | Direct | 0 |
Reported balance
After 2025-12-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-05 · Disposition to issuer · Disposed 8,637 · Balance 0 F2: Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options. F1: This Form 4 reports securities disposed of pursuant to the terms of the Transaction Agreement (the "Agreement"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. ("Sub"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, pursuant to which Sub acquired all the issued and to be issued share capital of the Issuer (the "Acquisition") for a cash purchase price of $2.035 per share (the "Scheme Consideration"). The Acquisition was completed as of December 5, 2025 (the "Effective Time"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.35 · Expires 2034-05-29 | Direct | 0 |
Reported balance
After 2025-12-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-05 · Disposition to issuer · Disposed 8,462 · Balance 0 F2: Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.61 · Expires 2033-12-13 | Direct | 0 |
Reported balance
After 2025-12-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-05 · Disposition to issuer · Disposed 15,021 · Balance 0 F2: Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Transaction Agreement (the "Agreement"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. ("Sub"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, pursuant to which Sub acquired all the issued and to be issued share capital of the Issuer (the "Acquisition") for a cash purchase price of $2.035 per share (the "Scheme Consideration"). The Acquisition was completed as of December 5, 2025 (the "Effective Time").
F2: Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 416 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 7 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,061.292 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 6 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,645.292 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 2,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 5 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,015.292 F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 4 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,975.292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,966.292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 4,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,263.292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| March 07, 2013 Filed Mar 11, 2013 20:40 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 34,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,133.292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award. Read SEC document |
| March 03, 2013 Filed Mar 5, 2013 21:26 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 3,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006628 · doc4.xml · derivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 3,753 shares Expires 2013-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: Represents vesting of one-quarter of restricted stock units granted on March 3, 2009. This is the final vesting of this award. F1 · derivative.expiration_date: Represents vesting of one-quarter of restricted stock units granted on March 3, 2009. This is the final vesting of this award. Read SEC document |
| March 03, 2013 Filed Mar 5, 2013 21:26 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,393 | $37.15 | $51,749.95 |
DisclosureSEC source: 0001225208-13-006628 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,958.292 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 03, 2013 Filed Mar 5, 2013 21:26 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006628 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,351.292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted stock units granted on March 3, 2009. This is the final vesting of this award. Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 21:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 6,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-022364 · doc4.xml · derivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,332 Underlying: Common Stock, $0.10 par value · 6,668 shares Expires 2014-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Represents vesting of one third of restricted stock units granted on November 2, 2009. The balance of the award is scheduled to to vest in two equal installments on the fourth and fifth anniversaries of the grant date. F3 · derivative.expiration_date: Represents vesting of one third of restricted stock units granted on November 2, 2009. The balance of the award is scheduled to to vest in two equal installments on the fourth and fifth anniversaries of the grant date. Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 21:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,091 | $33.18 | $102,559.38 |
DisclosureSEC source: 0001225208-12-022364 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,598.82 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| November 02, 2012 Filed Nov 5, 2012 21:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 6,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-022364 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,689.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 32,300 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · derivative · entry 7 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 32,300 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 55,463 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · derivative · entry 6 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 55,463 shares Expires 2018-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 59,855 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · derivative · entry 5 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,952 Underlying: Common Stock, $0.10 par value · 59,855 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second and third anniversaries of the grant date, which was March 3, 2009. The remainder of the stock option award will vest on March 3, 2013, the fourth anniversary of the grant date. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 118,190 | $32.89 | $3,887,269.10 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 4 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,021.82 F1 · price: Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.86 to $32.92, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 32,300 | $22.73 | $734,179.00 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,211.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 55,463 | $22.14 | $1,227,950.82 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,911.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2012 Filed Sep 4, 2012 20:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 59,855 | $17.51 | $1,048,061.05 |
DisclosureSEC source: 0001225208-12-018890 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,448.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherPerformance Shares · Derivative | 461 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 10 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,719 Underlying: Common Stock, $0.10 par value · 461 shares Expires 2014-03-31 F13 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F14 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award. F13 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. F13 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 10,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 9 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,258 Underlying: Common Stock, $0.10 par value · 10,258 shares Expires 2014-03-31 F11 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F12 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award. F11 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. F11 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 12,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 8 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 12,428 shares Expires 2012-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 6,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 7 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,428 Underlying: Common Stock, $0.10 par value · 6,370 shares Expires 2012-03-31 F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · shares: Represents performance shares earned under the 2009-2011 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 5,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 6 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,930.8092 Underlying: Common Stock, $0.10 par value · 5,438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherPerformance Shares · Derivative | 985.2592 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 5 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,368.8092 Underlying: Common Stock, $0.10 par value · 985.2592 shares Expires not disclosed F7 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F8 · shares: Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award. F7 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. F7 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 11,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 4 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,383.55 Underlying: Common Stock, $0.10 par value · 11,567 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F6 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 12,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · derivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,038 Underlying: Common Stock, $0.10 par value · 12,038 shares Expires 2016-03-06 F3 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 6,931 | $32.33 | $224,079.23 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,593.82 F2 · shares: Shares withheld for payment of taxes upon distribution of the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 06, 2012 Filed Mar 9, 2012 21:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 17,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-007185 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,524.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents distribution of performance shares earned under the 2009-2011 Long-Term Performance Award. Read SEC document |
| March 04, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 3,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · derivative · entry 14 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 3,039 shares Expires 2012-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: Represents vesting of one-quarter of restricted stock units granted on March 4, 2008. The award has fully vested. F7 · derivative.expiration_date: Represents vesting of one-quarter of restricted stock units granted on March 4, 2008. The award has fully vested. Read SEC document |
| March 04, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,105 | $32.59 | $36,011.95 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 10 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,658.82 F6 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 04, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 9 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,763.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Represents vesting of one-quarter of restricted stock units granted on March 4, 2008. The award has fully vested. Read SEC document |
| March 03, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 3,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · derivative · entry 13 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,753 Underlying: Common Stock, $0.10 par value · 3,753 shares Expires 2013-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: Represents vesting of one-quarter of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. F5 · derivative.expiration_date: Represents vesting of one-quarter of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| March 03, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,365 | $32.59 | $44,485.35 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 8 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,724.82 F6 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| March 03, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 7 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,089.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fourth anniversary of the grant date. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 4,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · derivative · entry 12 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,370 Underlying: Common Stock, $0.10 par value · 4,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,983 | $32.59 | $64,625.97 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 6 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,336.82 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 5 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,319.82 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 02, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 4,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 4 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,995.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · derivative · entry 11 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500 Underlying: Common Stock, $0.10 par value · 3,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the vesting date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F1 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,711 | $32.64 | $55,847.04 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,865.82 F3 · shares: Shares withheld for payment of taxes upon vesting of market share units. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,576.82 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 01, 2012 Filed Mar 6, 2012 00:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-006728 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,573.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date. Read SEC document |
| May 01, 2011 Filed May 2, 2011 20:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,236 | $28.10 | $34,731.60 |
DisclosureSEC source: 0001225208-11-012774 · doc4.xml · nonDerivative · entry 1 Cuss Francis M · CIK 0001490216 · SVP Research, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,871.82 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| March 06, 2011 Filed Mar 8, 2011 22:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009175 · doc4.xml · derivative · entry 6 Cuss Francis M · CIK 0001490216 · SVP Dscvry & Exp Clinl Resrch 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,438 shares Expires 2011-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock. F5 · derivative.expiration_date: Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock. Read SEC document |
| March 06, 2011 Filed Mar 8, 2011 22:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 974 | $26.43 | $25,742.82 |
DisclosureSEC source: 0001225208-11-009175 · doc4.xml · nonDerivative · entry 4 Cuss Francis M · CIK 0001490216 · SVP Dscvry & Exp Clinl Resrch 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,107.82 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2011 Filed Mar 8, 2011 22:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009175 · doc4.xml · nonDerivative · entry 3 Cuss Francis M · CIK 0001490216 · SVP Dscvry & Exp Clinl Resrch 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,081.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 22:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 3,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009175 · doc4.xml · derivative · entry 5 Cuss Francis M · CIK 0001490216 · SVP Dscvry & Exp Clinl Resrch 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,039 Underlying: Common Stock, $0.10 par value · 3,038 shares Expires 2012-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock. F5 · derivative.expiration_date: Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 22:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,105 | $26.43 | $29,205.15 |
DisclosureSEC source: 0001225208-11-009175 · doc4.xml · nonDerivative · entry 2 Cuss Francis M · CIK 0001490216 · SVP Dscvry & Exp Clinl Resrch 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,643.82 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.